Epzicom abacavir/lamivudine regulatory update

FDA approved Epzicom, a fixed-dose once-daily combination of GSK's Epivir lamivudine and Ziagen abacavir, to treat HIV in combination with other anti-retrovirals. GSK began a voucher program to provi...